Trials / Completed
CompletedNCT03578107
Improve Acute Reperfusion Treatment Quality for Stroke in China, IMPROVE: Stroke Care in China
Improve Acute Reperfusion Treatment Quality for Stroke in China
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15,895 (actual)
- Sponsor
- Beijing Tiantan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In order to bridge the great gaps, Chinese Stroke Association (CSA) and American Heart Association (AHA) sought to develop, conduct, and assess a multifaceted quality improvement intervention to increase the adherent rate of IV tPA and ET and improve 3-month clinical outcomes for these patients through our cluster-randomized stepped-wedge IMPROVE: Stroke in China trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | improvement of quality of stroke care | 1. hospital tool kits for quality improvement of reperfusion therapy ; 2. organizational stakeholder and opinion leader meetings; 3. data monitoring and feedback reports； 4. webinar for hospital teams |
Timeline
- Start date
- 2018-07-01
- Primary completion
- 2020-07-31
- Completion
- 2020-10-31
- First posted
- 2018-07-05
- Last updated
- 2021-11-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03578107. Inclusion in this directory is not an endorsement.